{"company":{"id":2022042,"name":"Blue Matter","domain":"bluematterconsulting.com","url":"https://alion.io/company/bluematterconsulting"},"section":"news","answer":"Blue Matter: 20 headlines on record, 15 headlines in the last 90 days. Its story counts 1 milestone.","figures":[{"label":"Headlines","value":"20"},{"label":"In 90 days","value":"15"},{"label":"Milestones","value":"1"}],"blocks":[{"key":"news","title":"Headlines","source":"the outlets named on each headline, each story once","rows":16},{"key":"story","title":"Milestones","source":"Each milestone is dated by its source: registers, filings, the press","rows":1}],"news":[{"date":"2026-10-28","kind":"News","title":"Blue Matter 'turbocharges' global reach of comms agency Cognite with acquisition","source":"fiercepharma.com","url":"https://fiercepharma.com/marketing/blue-matter-turbocharges-global-reach-comms-agency-cognite-acquistion"},{"date":"2026-10-28","kind":"News","title":"Blue Matter Acquires Cognite, a Leading Healthcare Communications Agency","source":"afp.com","url":"https://afp.com/en/infos/blue-matter-acquires-cognite-leading-healthcare-communications-agency"},{"date":"2026-10-22","kind":"Blog","title":"Looking Ahead to 2027: Observations on Evolving Oncology Policy and Treatment Access","url":"https://bluematterconsulting.com/insights/blog/policy-avbcc-2027-oncology-access/"},{"date":"2026-10-16","kind":"Blog","title":"Study Report: Key Success Factors for Building a Best Practice Launch Organization","url":"https://bluematterconsulting.com/insights/whitepaper/study-report-key-succebest-practice-launch-organization-report/"},{"date":"2026-10-13","kind":"Blog","title":"What Cell & Gene Meeting on the Mesa Told Us About CGT's Hardest Problems","url":"https://bluematterconsulting.com/insights/blog/cell-gene-meeting-on-the-mesa-2026-recap/"},{"date":"2026-10-09","kind":"Blog","title":"2026 London Biopharma Discussion Synthesis","url":"https://bluematterconsulting.com/insights/whitepaper/2026-london-biopharma-discussion-synthesis/"},{"date":"2026-10-05","kind":"Blog","title":"Translating Innovation Into Patient Reach: Recaps from Two Blue Matter Panels at the 2026 LSX Congress USA","url":"https://bluematterconsulting.com/insights/whitepaper/lsx-congress2026-blue-matter-panel-recaps/"},{"date":"2026-10-01","kind":"Blog","title":"From Promise to Practice: Five Questions Shaping the Future of Psychedelic Medicine","url":"https://bluematterconsulting.com/insights/whitepaper/five-questions-shaping-future-psychedelic-medicine/"},{"date":"2026-09-30","kind":"News","title":"Blue Matter Launches Behavioral Science Center of Excellence to Decode and Predict Health Care Decisions in a Rapidly Evolving Biopharma Landscape","source":"afp.com","url":"https://afp.com/en/infos/blue-matter-launches-behavioral-science-center-excellence-decode-and-predict-health-care"},{"date":"2026-09-25","kind":"Blog","title":"E-Book: Critical Success Factors for Commercializing Cell & Gene Therapies","url":"https://bluematterconsulting.com/insights/ebook/e-book-critical-success-factors-commercializing-cell-gene-therapies/"},{"date":"2026-09-16","kind":"Blog","title":"Critical Success Factors for Commercializing Cell & Gene Therapies (10): External Communications - Controlling the Launch Narrative Before the Market Writes Its Own","url":"https://bluematterconsulting.com/insights/blog/critical-success-factors-cell-gene-therapies-10-external-communications/"},{"date":"2026-08-28","kind":"Blog","title":"Maintaining US Life Science Innovation Leadership Requires Continued Policy Focus, Especially in Rare Disease","url":"https://bluematterconsulting.com/insights/blog/policy-focus-timing-us-approvals-vs-ex-us-approvals/"},{"date":"2026-06-09","kind":"News","title":"Blue Matter Expands Capabilities in Healthcare Policy Support for Life Sciences Led by Partner, Milena Sullivan","source":"YahooFinance","url":"https://finance.yahoo.com/sectors/healthcare/articles/blue-matter-expands-capabilities-healthcare-130100699.html"},{"date":"2026-01-13","kind":"News","title":"Blue Matter Establishes New Capabilities in Biopharma Research & Development Led by Partner, Tara Austraat-Churik","source":"YahooFinance","url":"https://finance.yahoo.com/news/blue-matter-establishes-capabilities-biopharma-140100794.html"},{"date":"2024-09-25","kind":"News","title":"Blue Matter Buys Healthcare-Focused PR Company Sam Brown","source":"Pulse 2.0","url":"https://pulse2.com/blue-matter-buys-healthcare-focused-pr-company-sam-brown/"},{"date":"2024-09-18","kind":"Press release","title":"Blue Matter Acquires Sam Brown Inc., a Leading Healthcare Corporate Communications and Public Relations Agency","source":"businesswire","url":"https://businesswire.com/news/home/20240918653452/en/Blue-Matter-Acquires-Sam-Brown-Inc.-a-Leading-Healthcare-Corporate-Communications-and-Public-Relations-Agency"}],"story":[{"title":"Founded"}],"as_of":"2026-11-16","cite":"Blue Matter, News. Alion, Nov 16, 2026. https://alion.io/company/bluematterconsulting/news","html_url":"https://alion.io/company/bluematterconsulting/news","json_url":"https://alion.io/company/bluematterconsulting/news.json","license":"CC BY-SA 4.0","meta":{"source":"Alion","generated_at":"2026-11-16T09:17:31Z"}}